Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Conavi MedicalFRA:YU1 -6.15% OCF Margin % is -5,158.54% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Conavi Medical ranks worse than 96.56% on this metric.
The historical rank and industry rank for Conavi Medical's OCF Margin % or its related term are showing as below:
FRA:YU1'
s OCF Margin % Range Over the Past 10 Years
Min: -932.3 Med: -603.73 Max: -275.16
Current: -3072.67
During the past 2 years, the highest OCF Margin % of Conavi Medical was -275.16%. The lowest was -932.30%. And the median was -603.73%.
FRA:YU1's OCF Margin % is ranked worse than 96.56% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs FRA:YU1: -3072.67
Conavi Medical OCF Margin % Related Terms
Conavi Medical OCF Margin % Historical Data
* Premium members only.
The historical data trend for Conavi Medical's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Conavi Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conavi Medical OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conavi Medical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Conavi Medical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Conavi Medical (FRA:YU1) has a OCF Margin % of -5,158.54% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Conavi Medical and its competitors. According to the industry distribution chart, Conavi Medical ranks #787 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 96.6%.
Is Conavi Medical's OCF Margin % too high?
Conavi Medical's current OCF Margin % is -5,158.54%. Based on the distribution chart, Conavi Medical ranks #787 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Conavi Medical's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Conavi Medical ranks #787 out of 815 companies for OCF Margin %. This places Conavi Medical in the lower half of its industry. The industry median OCF Margin % is 5.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Conavi Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Conavi Medical's current OCF Margin % is -5,158.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conavi Medical stock overvalued right now?
Conavi Medical (FRA:YU1) has a current OCF Margin % of -5,158.54%. The current OCF Margin % is -5,158.54%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Conavi Medical (FRA:YU1), the current OCF Margin % is -5,158.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:YU1 has been successfully added to your 
